Contraception: CHC products Flashcards

1
Q

CHC tablet benefits

A

Regulates blood loss, good for anemia, endometriosis, fibroids, decreased cramps
Increased spontaneity, sexual enjoyment, easy to use
Decreased chance of ovarian, endometrial, colorectal cancers, benign breast mass
Improved acne and hirsutism, effective, increased BMD which protects against OP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CHC ring benefits

A

Less spotting than with CHC tablets, low risk of irregular bleeding
Good for forgetful patients
Protects against same cancers as CHC tabs
Non-latex, Nuvaring has a grace period of 35 days, less ADEs due to less hormone present, can remove during intercourse for up to 3 hours, have to remember to replace and wash, can use with tampon, privacy, partner awareness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CHC patch benefits

A

Menstrual, sexual/psychological, and cancers are the same as the pills and ring

Have a grace period of up to 9 days, okay if you forget to change the patch after 7 days, can bathe/swim/etc. in it, readily reversible and effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CHC tablet disadvantages

A

Spotting (but goes away in 3 months), post-pill amenorrhea
Mood changes, daily administration, can be expensive, adherence issues, decreased libido and anorgasmia
May increase risk for cervical and possibly breast cancer
No STD protection, drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CHC ring disadvantages

A

Menstrual disadvantages the same as CHC tablets
Insertion and removal, discomfort during intercourse since you technically shouldn’t be removing it
Nuvaring requires refrigeration (Annovera doesn’t)
Systemic absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CHC patch disadvantages

A

Menstrual, sexual/psychological, cancers are the same as the CHC tablets

Clot risk, skin irritation, need to rotate site (back, butt, upper arm, abdomen) which means it may show and patients may not like the appearance of it/less privacy, patch detachment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CHC patch is CI’ed in…

A

obese women

90kg for Xulane, BMI >30 kg/m^2 for Twirla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CHC tabs ADEs

A

Nausea, bloating, breakthrough bleeding (but goes away in 2-3 months so patients should hold out until then to switch to a different method)

ACHES:

Abdominal pain
Chest pain
Headache
Eye problems
Severe leg pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CHC ring ADEs

A

ACHES, device-related events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CHC patch ADEs

A

Higher incidence of blood clots, irritation at patch site, ACHES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When do you decrease estrogen content?

A

Nausea, breast tenderness, headaches, cyclic weight gain, dysmenorrhea, menorrhagia, uterine fibroid growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When do you increase estrogen content

A

Breakthrough bleeding on days 1-9 of the cycle, vasomotor symptoms, nervousness, decreased libido

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When do you decrease progestin content?

A

Increased appetite, weight gain, bloating, constipation, acne, oily skin, hirsutism, depression, fatigue, irritability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When do you increase progestin content?

A

Dysmenorrhea, menorrhagia, late-cycle breakthrough bleeding (days 10-21)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What to do if you miss a dose/insertion/application of a tablet/patch/ring in <48 hours

A

Do it as soon as you remember, no BUM or EC needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What to do if you miss a dose/insertion/application and it’s been >48 hours

A

Do it as soon as you remember, use BUM for a week, EC should be considered if the dose/insertion/attachment occurred within the first week and unprotected sex happened in the previous 5 days